Scientific
MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis
These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.
MK5 Proteome Network Type I Analysis

Type 1 network in which we propagated the absolute log regulation ratio abs(log(r/g)). We used the filtered lowest boundary of the confidence interval for the microarray measurement based and used the high confidence interaction map. Because type-I networks tend to favour highly connected proteins we tested a normalisation scheme in which we would run the network once with real values (the measured column) and once with simulated values where each measured point is set to 1 instead of the actual signal (the expected column). Afterwards we divided the measured value by the expected value. This normalisation scheme works to a certain extend but will lead to a variance that is directly related to the connectivity of each protein. In the end we dropped the use of Type-I networks due to the many technical problems they pose.
Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
measured Hugo Gene Rank description expected final
Results: HTML CSV LaTeX
Showing element 551 to 600 of 3206 in total

\def\wcA{0.14285714285714\textwidth}
\def\wcB{0.14285714285714\textwidth}
\def\wcC{0.14285714285714\textwidth}
\def\wcD{0.14285714285714\textwidth}
\def\wcE{0.14285714285714\textwidth}
\def\wcF{0.14285714285714\textwidth}
\begin{longtable}{|c|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
measured\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
Hugo\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
expected\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
final\vspace{3pt}}\\
\hline
\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
0.0385694\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
SLMO2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
740\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
PROTEIN C20ORF45 (CGI-107). \vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
0.145821\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
0.264498255\vspace{3pt}}}\\\cline{2-4}
&\parbox{\wcB}{\vspace{3pt}\noindent
ZCCHC8\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
741\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
\vspace{3pt}}}&&\\\cline{1-3}\cline{5-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
0.0386201\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
ATP13A4\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1192\vspace{3pt}}&&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
0.155349\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
0.24860218\vspace{3pt}}}\\\cline{2-4}
&\parbox{\wcB}{\vspace{3pt}\noindent
TBP\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1191\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
TATA BOX BINDING PROTEIN (TRANSCRIPTION INITIATION FACTOR TFIID) (TATA-BOX FACTOR) (TATA SEQUENCE-BINDING PROTEIN) (TBP). \vspace{3pt}}&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
0.0386224\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
NDST2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
2202\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
HEPARIN SULFATE N-DEACETYLASE/N-SULFOTRANSFERASE (EC 2.8.2.-) (N- HSST) (N-HEPARIN SULFATE SULFOTRANSFERASE) (GLUCOSAMINYL N- DEACETYLASE/N-SULFOTRANSFERASE). \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.17129\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.225479596\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
0.038631\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1433\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
RNA HELICASE-RELATED PROTEIN; RNA HELICASE-LIKE PROTEIN; SF3B125 DEAD-BOX PROTEIN. \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.158546\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.243657992\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
0.038682\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
TCP11L1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
2125\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.169567\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.228122217\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
0.0387072\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
EEA1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1807\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
"EARLY ENDOSOME ANTIGEN 1, 162KD; EARLY ENDOSOME-ASSOCIATED PROTEIN. \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.165025\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.234553552\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
0.0387137\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
UCHL5\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1126\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
UBIQUITIN CARBOXYL-TERMINAL HYDROLASE ISOZYME L5 (EC 3.4.19.12) (UCH- L5) (UBIQUITIN THIOLESTERASE L5) (UBIQUITIN C-TERMINAL HYDROLASE UCH37) (CGI-70) (AD-019). \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.154436\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.250677951\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
0.0387861\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SRRM2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1435\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
SPLICING COACTIVATOR SUBUNIT SRM300; RNA BINDING PROTEIN; AT-RICH ELEMENT BINDING FACTOR. \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.159183\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.2436573\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
0.038802\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
FAM20A\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
3087\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.397415\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.097635972\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
0.0388043\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
2441\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
MYO-INOSITOL 1-PHOSPHATE SYNTHASE A1. \vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
0.178742\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
0.217096709\vspace{3pt}}}\\\cline{2-4}
&\parbox{\wcB}{\vspace{3pt}\noindent
UBL4A\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
2442\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
UBIQUITIN-LIKE PROTEIN GDX (UBIQUITIN-LIKE PROTEIN 4). \vspace{3pt}}&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
0.0388254\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
MRPL30\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1613\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
MITOCHONDRIAL RIBOSOMAL PROTEIN L30 ISOFORM A. \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.161954\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.239731035\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
0.0388692\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
C19orf2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1124\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
RNA POLYMERASE II SUBUNIT 5-MEDIATING PROTEIN (RPB5-MEDIATING PROTEIN). \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.155056\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.250678465\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
0.0388966\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
C16orf80\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1122\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
TRANSCRIPTION FACTOR IIB. \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.155152\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.25069995899999997\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
0.0389051\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
GMPPA\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1086\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
GDP-MANNOSE PYROPHOSPHORYLASE A; MANNOSE-1-PHOSPHATE GUANYLYLTRANSFERASE (GDP). \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.154417\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.251948296\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
0.038917\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
3169\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
RIBOSOMAL PROTEIN S6 KINASE-LIKE 1. \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.619812\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.062788394\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
0.0389372\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
TXNDC9\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1960\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
PROTEIN 1-4 (ATP BINDING PROTEIN ASSOCIATED WITH CELL DIFFERENTIATION). \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.1684\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.231218527\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
0.0389719\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
CCDC12\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
377\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.139616\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.279136345\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
0.0391008\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
3042\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
GUANINE NUCLEOTIDE-BINDING PROTEIN G(I)/G(S)/G(O) GAMMA-7 SUBUNIT. \vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
0.366305\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
0.106743834\vspace{3pt}}}\\\cline{2-4}
&\parbox{\wcB}{\vspace{3pt}\noindent
GNG12\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
3043\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
GUANINE NUCLEOTIDE-BINDING PROTEIN G(I)/G(S)/G(O) GAMMA-12 SUBUNIT. \vspace{3pt}}&&\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
0.0391646\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
C6orf32\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
963\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
0.152962\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
0.25604137\vspace{3pt}}}\\\cline{2-4}
&\parbox{\wcB}{\vspace{3pt}\noindent
TGS1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
962\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
PRIP-INTERACTING PROTEIN PIPMT; PRIP-INTERACTING PROTEIN WITH METHYLTRANSFERASE DOMAIN. \vspace{3pt}}&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
0.0391808\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
RRAGA\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
3200\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
RAS-RELATED GTP BINDING A; RAS-RELATED GTP-BINDING PROTEIN. \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.63989\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.023892334\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
0.0391877\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
HIVEP3\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1351\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
HUMAN IMMUNODEFICIENCY VIRUS TYPE I ENHANCER BINDING PROTEIN 3. \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.159829\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.245185167\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
0.0392019\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
GNA11\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
3054\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
"GUANINE NUCLEOTIDE-BINDING PROTEIN G(Y), ALPHA SUBUNIT (ALPHA-11). \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.371714\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.105462533\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
0.0393162\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
CPE\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1113\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
CARBOXYPEPTIDASE H PRECURSOR (EC 3.4.17.10) (CPH) (CARBOXYPEPTIDASE E) (CPE) (ENKEPHALIN CONVERTASE) (PROHORMONE PROCESSING CARBOXYPEPTIDASE). \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.156752\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.250817852\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
0.0393961\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
CHCHD4\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1325\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
0.160458\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
0.245522816\vspace{3pt}}}\\\cline{2-4}
&\parbox{\wcB}{\vspace{3pt}\noindent
MRPS26\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1324\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
"28S RIBOSOMAL PROTEIN S26, MITOCHONDRIAL PRECURSOR (MRP-S26) (MRP- S13). \vspace{3pt}}&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
0.039427\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PPIH\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1887\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
PEPTIDYL PROLYL ISOMERASE H; CYCLOPHILIN H. \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.1694\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.232744982\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
0.0394801\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1567\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
NEFA-INTERACTING NUCLEAR PROTEIN NIP30. \vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
0.163824\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
0.240990941\vspace{3pt}}}\\\cline{2-4}
&\parbox{\wcB}{\vspace{3pt}\noindent
ARL1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1566\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
ADP-RIBOSYLATION FACTOR-LIKE PROTEIN 1. \vspace{3pt}}&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
0.0394844\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ZMAT2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
456\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.143261\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.275611646\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
0.0395353\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SLC13A3\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
2657\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
"SOLUTE CARRIER FAMILY 13, MEMBER 3 (SODIUM-DEPENDENT HIGH-AFFINITY DICARBOXYLATE TRANSPORTER 2) (NA(+)/DICARBOXYLATE COTRANSPORTER 3) (NADC-3) (HNADC3). \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.188319\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.209937924\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
0.0395402\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
EXDL2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
814\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.151289\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.261355419\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
0.0395834\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
GNAQ\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
3055\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
"GUANINE NUCLEOTIDE-BINDING PROTEIN G(Q), ALPHA SUBUNIT. \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.375337\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.105460959\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
0.0395897\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
HTATIP\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
981\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
60 KDA TAT INTERACTIVE PROTEIN (TIP60) (HIV-1 TAT INTERACTIVE PROTEIN) (CPLA(2) INTERACTING PROTEIN). \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.155084\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.255279075\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
0.0396993\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
C16orf57\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
343\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.139829\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.283913208\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
0.0397033\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}}&\parbox{\wcC}{\vspace{3pt}\noindent
1040\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
"ATP-DEPENDENT DNA HELICASE II, 70 KDA SUBUNIT (LUPUS KU AUTOANTIGEN PROTEIN P70) (KU70) (70 KDA SUBUNIT OF KU ANTIGEN) (THYROID-LUPUS AUTOANTIGEN) (TLAA) (CTC BOX BINDING FACTOR 75 KDA SUBUNIT) (CTCBF) (CTC75). \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.156754\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.253284127\vspace{3pt}}\\\cline{1-1}\cline{3-6}
\parbox{\wcA}{\vspace{3pt}\noindent
0.039713\vspace{3pt}}&&\parbox{\wcC}{\vspace{3pt}\noindent
878\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
PUTATIVE PRE-MRNA SPLICING FACTOR RNA HELICASE (ATP-DEPENDENT RNA HELICASE #3) (DEAH-BOX PROTEIN 16). \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.15268\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.260106104\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
0.0397949\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ARHGAP23\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
424\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.143472\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.277370497\vspace{3pt}}\\\cline{1-3}\cline{5-6}
\parbox{\wcA}{\vspace{3pt}\noindent
0.0398119\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
MTERFD1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
2981\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
0.285269\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.139559153\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
0.0398596\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PCSK5\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
3086\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
PROPROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE 5 PRECURSOR (EC 3.4.21.-) (PROPROTEIN CONVERTASE PC5) (SUBTILISIN/KEXIN-LIKE PROTEASE PC5) (CONVERTASE PC5) (PC6) (HPC6). \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.408247\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.09763599\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
0.0398851\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
COG3\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
728\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
CONSERVED OLIGOMERIC GOLGI COMPLEX COMPONENT 3 (VESICLE DOCKING PROTEIN SEC34 HOMOLOG) (P94). \vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
0.150694\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
0.264676099\vspace{3pt}}}\\\cline{2-4}
&\parbox{\wcB}{\vspace{3pt}\noindent
ZMYM4\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
727\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
ZINC FINGER PROTEIN 262; CELL DEATH INHIBITING RNA. \vspace{3pt}}&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
0.0399967\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
534\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
SMALL NUCLEAR RIBONUCLEOPROTEIN E (SNRNP-E) (SM PROTEIN E) (SM-E) (SME). \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.14739\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.271366443\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
0.040067\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
RALGPS2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
920\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
RAL-A EXCHANGE FACTOR RALGPS2. \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.155337\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.257935971\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
0.0401118\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
BUD13\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1295\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
0.163123\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
0.245899107\vspace{3pt}}}\\\cline{2-4}
&\parbox{\wcB}{\vspace{3pt}\noindent
EVI5L\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1296\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
SIMILAR TO ECOTROPIC VIRAL INTEGRATION SITE 5; NEUROBLASTOMA STAGE 4S GENE. \vspace{3pt}}&&\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Hugo is the bloody hugo identifier as demanded by the BMC Bioinformatics idiots
- http://analysis.yellowcouch.org/